Speciality
Spotlight

 




           

Clinical Pharmacology

       

     





Drug
Evaluation

   

  • Lowe 
    M.N. & Lamb H.M.

    Meropenem
    – An updated Review of its use in the Management of Intra-Abdominal
    Infections

    Drugs,
    Sept 2000; 60 : 619-646

      


    Meropenem
    is a carbapenem antibacterial agent with a broad spectrum of
    activity which encompasses Gram negative, Gram positive and
    anaerobic bacteria. It is resistant to beta lactamases.

       

    In
    patients with moderate to severe intra-abdominal infections,
    empirical monotherapy with meropenem achieved clinical response
    rates ranging from 91% to 100% in 7 randomised comparative trials.

       



  
 



 

     

Speciality Spotlight

 

           
Clinical Pharmacology
       

     

Drug Evaluation
   

  • Lowe  M.N. & Lamb H.M.
    Meropenem – An updated Review of its use in the Management of Intra-Abdominal Infections
    Drugs, Sept 2000; 60 : 619-646
      
    Meropenem is a carbapenem antibacterial agent with a broad spectrum of activity which encompasses Gram negative, Gram positive and anaerobic bacteria. It is resistant to beta lactamases.
       
    In patients with moderate to severe intra-abdominal infections, empirical monotherapy with meropenem achieved clinical response rates ranging from 91% to 100% in 7 randomised comparative trials.
       

    

 

By |2022-07-20T16:42:15+00:00July 20, 2022|Uncategorized|Comments Off on Drug Evaluation

About the Author: